Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Caring Connections: A Program to Alleviate Social Isolation and Loneliness in Individuals Living With Spinal Cord Injury

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05295108
Recruitment Status : Not yet recruiting
First Posted : March 24, 2022
Last Update Posted : February 8, 2023
Sponsor:
Information provided by (Responsible Party):
Sherri LaVela, Chicago Association for Research and Education in Science

Brief Summary:
This study will use a randomized controlled design with an active attention control group to evaluate an intervention intended to reduce social isolation and loneliness in persons with SCI/D. The intervention, Caring Connections, is a peer-based intervention which is important because peers with SCI/D play an important role in improving quality of life, mental health, and social health in persons with SCI/D.

Condition or disease Intervention/treatment Phase
Spinal Cord Injuries and Disorders (SCI/D) Other: Caring Connections Other: Attention control Not Applicable

Detailed Description:
The overall study objective is to conduct and evaluate a fully powered randomized control trial (RCT) to assess changes in loneliness and social isolation outcomes between the Caring Connections intervention and attention control condition in community-dwelling individuals with SCI/D. The Caring Connections intervention (described in detail below) is a peer-based, facilitated, letter writing program designed to provide feelings of social connectedness and moments of positivity to reduce loneliness and social isolation in persons with SCI/D.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 62 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Randomized controlled trial comparing intervention with attention control condition.
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Caring Connections: A Program to Alleviate Social Isolation and Loneliness in Individuals Living With Spinal Cord Injury
Estimated Study Start Date : November 2023
Estimated Primary Completion Date : January 2024
Estimated Study Completion Date : April 29, 2025

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Caring Connections intervention
The Caring Connections intervention will consist of non-demanding, messages of care and concern delivered to individuals with SCI/D who had moderate to high social isolation and/or loneliness scores on the baseline survey. The caring messages will be in the form of structured, yet personalized mailed letters from one consistent peer with SCI/D, providing long-term and steady contact. Intervention participants will receive a letter every month over a 6-month period. Following a standardized set of principles, letters will contain cheerful expressions of care and micro-moments of positivity. The PI/Co-Is will provide a brief training and work with volunteer peers with SCI/D to write the letters.
Other: Caring Connections
peer-based letter writing social connectedness intervention to improve social health outcomes

Active Comparator: Attention control
We will mail informational materials to individuals with SCI/D in our control group at the same timepoints over 6 months as our intervention letter mailings. The informational materials will discuss life domains that are important to a good quality of life. Topics include community living, physical/healthy living, safety and security, social/spirituality, advocacy/engagement, and employment/volunteering. We will draw information for each topic from the Knowledge Translation Center SCI Factsheets (MSKTC 2021) and the LifeCourse Nexus library (2021).
Other: Attention control
informational materials provided to educate on life domains that are important to social health




Primary Outcome Measures :
  1. loneliness [ Time Frame: change from baseline to post-RCT (6 months) ]
    UCLA 3-item Loneliness Scale


Secondary Outcome Measures :
  1. social isolation [ Time Frame: change from baseline to post-RCT (6 months) ]
    PROMIS Social Isolation 8-item


Other Outcome Measures:
  1. social contact with friends/family [ Time Frame: change from baseline to post-RCT (6 months) ]
    frequency: Once a week, Several times a week, About once a month, Several times a year, About once or twice a year, Less than once a year, Never)

  2. social contact with organized groups (Examples include: a choir, a committee or board, a support group, a sports or exercise group, a hobby group, or a professional society.) [ Time Frame: change from baseline to post-RCT (6 months) ]
    frequency: Once a week, Several times a week, About once a month, Several times a year, About once or twice a year, Less than once a year, Never)

  3. perceived benefit from the intervention [ Time Frame: post-RCT at 6 months ]
    5-point Likert scale (No benefit, Minor benefit, Neutral, Moderate benefit, Major benefit)

  4. perceived negative impacts from the intervention [ Time Frame: post-RCT at 6 months ]
    5-point Likert scale (No negative impacts, Minor negative impacts, Neutral, Moderate negative impacts, Major negative impacts)

  5. satisfaction with the intervention [ Time Frame: post-RCT at 6 months ]
    5-point Likert scale (Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Our target population will include adult Veterans with chronic SCI/D (duration of injury > 1 year); this may include those with traumatic and non-traumatic SCI/D, and may include SCI, nonmalignant neoplasms resulting in neurologic deficit; vascular insults of a thromboembolic, hemorrhagic, or ischemic nature; cauda equina syndrome producing neurologic deficit; inflammatory disease of the spine, spinal cord, or cauda equina resulting in non-progressive neurologic deficit; and demyelinating disease of the spinal cord.

Exclusion Criteria:

  • Veterans with SCI/D under the age of 18 will be excluded. Individuals with new injuries (injury duration less than one year) will be excluded as it is plausible that social isolation and loneliness may more likely occur after the first year of injury when individuals have transitioned to the community and may no longer be surrounded by people consistently for help with their acute care needs (Dickson 2011). There are no SCI/D level or severity exclusions, as we wish to reach a diverse group of individuals.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05295108


Contacts
Layout table for location contacts
Contact: Sherri LaVela, PhD, MPH, MBA 708-202-5895 sherri.lavela@va.gov

Sponsors and Collaborators
Chicago Association for Research and Education in Science
Investigators
Layout table for investigator information
Principal Investigator: Sherri LaVela, PhD, MPH, MBA Department of Veterans Affairs, Hines VA
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Sherri LaVela, Research Health Scientist, Chicago Association for Research and Education in Science
ClinicalTrials.gov Identifier: NCT05295108    
Other Study ID Numbers: 864046
First Posted: March 24, 2022    Key Record Dates
Last Update Posted: February 8, 2023
Last Verified: February 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Cord Injuries
Wounds and Injuries
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System